Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)

BACKGROUND: The ‘treat to target’ paradigm improves outcomes and reduces costs in chronic disease management but is not yet established in psoriasis. OBJECTIVES: To identify treatment targets in psoriasis using two common measures of disease activity: Psoriasis Area and Severity Index (PASI) and Phy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahil, S.K., Wilson, N., Dand, N., Reynolds, N.J., Griffiths, C.E.M., Emsley, R., Marsden, A., Evans, I., Warren, R.B., Stocken, D., Barker, J.N., Burden, A.D., Smith, C.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317460/
https://www.ncbi.nlm.nih.gov/pubmed/31286471
http://dx.doi.org/10.1111/bjd.18333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317460/
https://www.ncbi.nlm.nih.gov/pubmed/31286471
http://dx.doi.org/10.1111/bjd.18333

Ejemplares similares